C

    Celularity Inc (CELU)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.85
    +0.27 (+17.09%)

    Market Cap: $45.73M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    53%(9/17)
    Avg Surprise
    -203.09%
    Streak
    1 Q
    PeriodReportedEst.SurpriseB/MYoY
    Mar 26
    		$-0.85N/AN/ABeat-42.5%
    Sep 25
    		$-0.88$-1.50+41.33%Beat-20.1%
    Jun 25
    		$-1.02$-0.75-36.13%Miss-243.9%
    Mar 25
    		$-0.60$-0.15-300.00%Miss+41.6%
    Dec 24
    		$-0.59N/AN/ABeat-18.9%
    Sep 24
    		$-0.73$-1.40+47.68%Beat-46.9%
    Jun 24
    		$-0.30$0.00N/ABeat+89.0%
    Mar 24
    		$-1.03$-1.40+26.66%Beat+75.0%
    Dec 23
    		$-0.50$-0.03-1566.67%Miss-108.3%
    Sep 23
    		$-0.50$-0.03-1561.67%Miss+80.8%
    Jun 23
    		$-2.70$-0.30-800.00%Miss-184.4%
    Mar 23
    		$-4.10$-2.40-70.83%Miss+14.6%
    Dec 22
    		$-0.24$-0.25+4.00%Beat-700.0%
    Sep 22
    		$-2.59$-3.05+15.08%Beat-164.8%
    Jun 22
    		$3.20$-2.60+223.08%Beat+219.0%
    Mar 22
    		$-4.80$-2.80-71.43%Miss-293.5%
    Dec 21
    		$-0.03N/A+90.32%Beat+76.9%
    Sep 21
    		$4.00$-3.45+215.94%Beat+400100.0%
    Jun 21
    		$-2.69$-0.16-1581.25%Miss-13350.0%
    Mar 21
    		$2.48$-0.14+1871.43%Beat+1966.7%
    Dec 20
    		$-0.13N/AN/ABeat-244.4%
    Sep 20
    		$-0.00N/AN/ABeat-100.8%
    Jun 20
    		$-0.02N/AN/ABeat-200.0%
    Mar 20
    		$0.12N/AN/ABeat+500.0%
    Dec 19
    		$0.09N/AN/ABeat-
    Sep 19
    		$0.13N/AN/ABeat-
    Jun 19
    		$0.02$0.00N/ABeat-
    Mar 19
    		$0.02$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.55EV/EBITDA-36.78x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-492.10%
    ROE-6367.00%ROIC253.21%
    Financial Health
    Debt/Equity-0.37xInterest Coverage-14.79x
    Current Ratio0.15xQuick Ratio0.15x
    Trading Statistics
    Beta0.54Avg Volume11.21M
    52-Week High$3.1552-Week Low$0.56

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.11
    SMA 20$0.90
    SMA 50$0.79
    SMA 200$1.13
    EMA 10$1.25
    EMA 20$1.03
    EMA 50$0.89
    EMA 200$1.14

    MACD

    Line: 0.22Signal: 0.09Hist: 0.13

    ADX

    ADX: 36.5+DI: 44.2-DI: 4.9

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down16.0
    PSAR$1.06

    Bollinger Bands

    Upper Band$1.74
    Lower Band$0.07
    %B Position18489%(Upper)
    Band Width1.07

    RSI (14-Day)

    Overbought
    72.5

    Momentum Oscillators

    Stoch %K62.2
    Stoch %D56.4
    Williams %R-37.4
    ROC (10d)165.8%
    Momentum1.15
    CCI (20d)209.6
    MFI (14d)92.5

    Volatility Measures

    ATR (14d)$0.28(14.9%)
    StdDev (20d)0.42
    Hist Vol503.7%(High)

    Volume Flow

    VWAP$1.73
    OBV224.4M
    AD Line88.2M
    CMF (20d)0.365

    Volume Metrics

    Avg Vol (20d)11.8M
    Vol Ratio0.3x(Low)
    VWMA (20d)$2.05

    Pivot Points

    R3$2.75
    R2$2.47
    R1$2.03
    Pivot Point$1.75
    S1$1.31
    S2$1.03
    S3$0.59

    Advanced Oscillators

    TSI43.03
    Ultimate Osc52.7
    KST485.46

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$4.10M$4.10M$5.28M$5.74M$18.13M$18.13M$9.30M$12.11M$14.68M$3.79M$3.79M$2.94M
    Cost of Revenue$-4,452,000$7.37M$2.02M$5.24M$7.34M$7.34M$3.88M$9.61M$1.64M$3.60M$3.60M$802,000
    Gross Profit$8.56M$-3,270,000$3.27M$494,000$10.79M$10.79M$5.41M$2.50M$13.04M$184,000$184,000$2.14M
    Operating Expenses$30.61M$26.16M$16.17M$16.36M$20.07M$27.61M$16.94M$-10,812,000$22.06M$99.44M$20.09M$44.61M
    R&D$3.35M$3.35M$4.60M$3.35M$3.83M$3.83M$3.92M$108.07M$5.84M$5.18M$5.18M$8.60M
    SG&A$0$15.06M$9.31M$12.63M$16.04M$16.06M$12.65M$13.02M$14.03M$13.07M$10.75M$12.83M
    Operating Income$-22,058,000$-22,058,000$-12,900,000$-15,864,000$-9,280,000$-9,473,000$-11,527,000$13.31M$-7,376,000$-99,256,000$-16,299,000$-42,476,000
    Interest Income$0$62,000$62,000$62,000$76,000$77,000$77,000$67,000$110,000$115,000$23,000$66,000
    Interest Expense$897,000$897,000$1.48M$1.94M$1.81M$1.81M$1.75M$663,000$1.15M$971,000$971,000$1.10M
    Income Before Tax$-24,359,000$-24,359,000$-23,076,000$-24,524,000$-13,293,000$-13,293,000$-16,098,000$9.56M$-22,013,000$-93,876,000$-93,876,000$-47,949,000
    Income Tax Expense$3,000$0$-3,000$0$13.49M$0$-13,489,000$10,000$0$2.11M$0$-3,197,000
    Net Income$-24,362,000$-24,362,000$-23,073,000$-24,524,000$-13,293,000$-13,293,000$-16,098,000$9.55M$-22,013,000$-93,876,000$-93,876,000$-47,949,000
    EBITDA$-21,659,000N/A$-19,733,000$-20,747,000$-7,597,000N/A$-12,452,000$-8,550,000N/A$-90,562,000N/A$-44,523,000
    EBIT$-23,462,000N/A$-21,599,000$-22,581,000$-9,473,000N/A$-14,346,000$-10,846,000N/A$-92,905,000N/A$-46,845,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CELU

    News

    Celularity Faces Nasdaq Listing Compliance Bid-Price Warning

    Celularity Inc. (CELU) has received a Nasdaq noncompliance notice as its stock traded below $1.00 for 30 consecutive business days, highlighting significant valuation and listing pressures. The company has until January 19, 2027, to regain compliance by maintaining a $1.00 closing bid price for 10 consecutive days, with a potential extension. Analysts currently rate CELU as a Buy with a $6.00 price target, while TipRanks’ AI Analyst, Spark, rates it Neutral due to weak financial health and bearish technical signals.

    TipRanks•7/29/26•
    Neutral

    Nasdaq issues bid-price deficiency notice to Celularity (NASDAQ: CELU)

    Celularity Inc. (NASDAQ: CELU) received a bid-price deficiency notice from Nasdaq because its Class A common stock traded below $1.00 for 30 consecutive business days. The company has 180 calendar days, until January 19, 2027, to regain compliance by having its closing bid price meet or exceed $1.00 for at least 10 consecutive business days. There is no assurance that Celularity will regain compliance, receive an extension, or avoid delisting.

    Stock Titan•7/29/26•
    Bearish

    Celularity Inc. (CELU) warrants delisted and deregistered from Nasdaq exchange

    Celularity Inc. (CELU) warrants have been delisted and deregistered from the Nasdaq Stock Market LLC. This action, initiated by Nasdaq, signifies that the warrants will have reduced public market visibility and liquidity. The delisting complies with Section 12(b) of the Securities Exchange Act of 1934 and related SEC rules for filing Form 25.

    Stock Titan•7/22/26•
    Bearish

    Insider trust lends $1M to Celularity (NASDAQ: CELU) on short term

    Celularity Inc. has secured a $1 million short-term loan from the Philip & Daniele Barach Family Trust, an entity linked to a significant shareholder. The loan features a 4.0% annual interest rate, which can rise to 18.0% upon default, and is collateralized by most of Celularity's personal property, maturing within 30 days unless certain financing events occur. Additionally, board member Vincent LeVien resigned, a departure the company states was not attributed to operational disputes.

    Stock Titan•6/30/26•
    Neutral

    Celularity Inc. Class A Actuals & Estimates (NASDAQ:CELU)

    This article provides an overview of Celularity Inc. (NASDAQ: CELU) stock, including its current price, market capitalization, volatility, and historical performance. It also details financial information such as net income, EBITDA, and the upcoming earnings release date, along with advice on how to buy the stock and its technical analysis ratings.

    TradingView•6/25/26•
    Bearish

    Frequently Asked Questions About CELU

    Does CELU pay dividends?
    Celularity Inc (CELU) does not currently pay a regular dividend.
    What is CELU's market cap?
    Celularity Inc (CELU) has a market capitalization of $45.73M with a current stock price of $1.85.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In